REPORTS BIGGER 4Q LOSS

Biotech firm Sunesis Pharmaceuticals Inc. on Friday reported a wider loss for the fourth quarter, despite higher revenue. Sunesis reported a loss after preferred dividends of $5.3 million, or 25 cents per share, compared with $4 million, or $2.94 per share, in the prior year.
MSN Money